Search peptides, terms, sources/
Research source · 2016

Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
2,463 postmenopausal women with osteoporosis (mean age 69), 28 sites in 10 countries
Sample size
2463
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

The teriparatide arm was open-label and served as a reference comparator, not a powered head-to-head test. The abstract text read does not give the fracture percentages. Trial registration NCT01343004.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.